BioCODE
Stellenbosch, South Africa
BioCODE is a South African medical technology startup spun out of Stellenbosch University, specializing in inflammation-centered diagnostic solutions. Their flagship product, Biolab Microclots, utilizes patented microclot detection technology involving fluorescent microscopy and flow cytometry to diagnose conditions such as Long COVID, cardiovascular diseases, and chronic inflammation. By developing point-of-care smart sensing solutions, BioCODE empowers healthcare professionals with advanced diagnostic tools capable of identifying blood anomalies missed by conventional tests. This approach shifts the clinical focus towards early prevention and management of chronic and post-viral syndromes, transforming healthcare delivery through accessible and accurate medical technologies.
Company Info
- Founded
- 2019
- Website
- www.biocode.co.za/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of BioCODE?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.